Jonathan R. McGrath
Algemeen Directeur bij Neograft Technologies, Inc.
Profiel
Jonathan R.
McGrath is currently the President, Chief Executive Officer & Director at Neograft Technologies, Inc. He was previously the Chief Executive Officer at LumeRx, Inc. Prior to that, he held Vice President positions in Research & Development at Pfizer Inc., Urologix, Inc., and BioSphere Medical, Inc. He completed his undergraduate degree at the University of Vermont.
Actieve functies van Jonathan R. McGrath
| Bedrijven | Functie | Begin |
|---|---|---|
Neograft Technologies, Inc.
 Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | Algemeen Directeur | - |
Eerdere bekende functies van Jonathan R. McGrath
| Bedrijven | Functie | Einde |
|---|---|---|
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 |
| UROLOGIX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 |
| PFIZER, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-1995 |
LumeRx, Inc.
 LumeRx, Inc. Medical SpecialtiesHealth Technology LumeRx, Inc. develops radiation technology that eliminates bacteria. It provides minimally invasive and light-based devices for the treatment of peptic ulcer disease. The company was founded by Robert A. Ganz and is headquartered in Newton, MA. | President | - |
Opleiding van Jonathan R. McGrath
| University of Vermont | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| UROLOGIX, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
LumeRx, Inc.
LumeRx, Inc. Medical SpecialtiesHealth Technology LumeRx, Inc. develops radiation technology that eliminates bacteria. It provides minimally invasive and light-based devices for the treatment of peptic ulcer disease. The company was founded by Robert A. Ganz and is headquartered in Newton, MA. | Health Technology |
Neograft Technologies, Inc.
Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | Commercial Services |
